Beth Shapiro

It's amazing.

Wild.

And it was such a rush, you know.

But it's a really great example of personalized medicine that right now, obviously, this is slow.

But we start somewhere and we always have to start somewhere.

Like, yes, it took six months and it's one baby and it took a lot of people to do this.

But this is the beginning of how we can use these tools to cure your cancer, to figure out how we can engineer a fix for a baby who's born with cystic fibrosis.

Or if you get blood cancer, can we edit the blood cells to make that cancer mutation just go away?

This is the beginning of these tools.

And for de-extinction and conservation, this is also just the beginning.

We've figured out how to learn DNA sequences from the past and actually transform that into an animal that has...

that's bigger than a gray wolf and it's more muscular than a gray wolf.

We've made dire wolves using dire wolf DNA and these amazing tools that we will have the potential to use to stop other species from becoming extinct.

I love it.

I think it is.

Obviously, there are risks associated with using technologies that we don't fully understand, but we're not taking those risks.

We're very carefully evaluating every single one of the edits that we make.

We are, in every case, interested in making the fewest number of changes possible to still bring those animals back.

Well, we have announced, obviously, the mammoth and the thylacine.

That's the Tasmanian tiger.